Virtus ETF Advisers LLC Black Diamond Therapeutics, Inc. Transaction History

Virtus ETF Advisers LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$5.18 - $8.48 $85,988 - $140,768	-16,600 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$8.46 - $12.42 $7,292 - $10,706	-862 Reduced 4.94%	16,600 $140,000
Q2 2021 Aug 10, 2021	BUY	$12.19 - $28.17 $106,126 - $245,248	8,706 Added 99.43%	17,462 $213,000
Q1 2021 May 17, 2021	BUY	$22.23 - $34.75 $3,401 - $5,316	153 Added 1.78%	8,756 $212,000
Q4 2020 Feb 12, 2021	SELL	$29.47 - $35.0 $9,341 - $11,095	-317 Reduced 3.55%	8,603 $276,000
Q3 2020 Nov 13, 2020	SELL	$26.17 - $43.07 $31,770 - $52,286	-1,214 Reduced 11.98%	8,920 $270,000
Q2 2020 Aug 05, 2020	BUY	$22.3 - $44.8 $225,988 - $454,003	10,134 New	10,134 $427,000

117

48.8M

1.84M

1.93M

Ticker BDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,339,500
Market Cap $78.1M
Description
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.